Loading clinical trials...
Loading clinical trials...
PROPHYLACTIC TREATMENT FOR CHEMO-INDUCED NEUTROPENIA. USE OF G-CSF BIOSIMILAR (NIVESTIM(REGISTERED)) ACCORDING TO THE CHEMOTHERAPY CONTEXT: ADJUVANT VERSUS METASTATIC.
Conditions
Interventions
Nivestim®
Locations
92
France
Clinique Rambot La Provençale Tour d'Aygosi
Aix-en-Provence, France
Centre Hospitalier du Pays d'Aix Service d'Hématologie - Oncologie
Aix-en-Provence, France
ICO Centre Paul Papin Service d'Oncologie Médicale
Angers, France
CHU - Hôtel-Dieu Service Hépato-Gastro-entérologie
Angers, France
CH d'Armentières Service Oncologie
Armentières, France
Centre Marie Curie A l'attention de Laëtitia
Arras, France
Start Date
September 1, 2014
Primary Completion Date
October 18, 2016
Completion Date
January 1, 2017
Last Updated
June 28, 2019
NCT06537726
NCT05245487
NCT04101760
NCT03251768
Lead Sponsor
Pfizer
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions